for the Period Ended 31 October 2024
| Profit and loss | |
| Balance sheet | |
| Additional notes | |
| Community Interest Report |
for the Period Ended
| 13 months to 31 October 2024 | ||
|---|---|---|
|
|
£ |
|
| Turnover: |
|
|
| Cost of sales: |
|
|
| Gross profit(or loss): |
|
|
| Distribution costs: |
|
|
| Administrative expenses: |
|
|
| Other operating income: |
|
|
| Operating profit(or loss): |
|
|
| Interest receivable and similar income: |
|
|
| Interest payable and similar charges: |
|
|
| Profit(or loss) before tax: |
|
|
| Tax: |
|
|
| Profit(or loss) for the financial year: |
|
As at
| Notes | 13 months to 31 October 2024 | ||
|---|---|---|---|
|
|
£ |
||
| Current assets | |||
| Cash at bank and in hand: |
|
||
| Total current assets: |
|
||
| Net current assets (liabilities): |
|
||
| Total assets less current liabilities: |
|
||
| Total net assets (liabilities): |
|
||
| Capital and reserves | |||
| Called up share capital: |
|
||
| Profit and loss account: |
|
||
| Total Shareholders' funds: |
|
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 October 2024
Basis of measurement and preparation
for the Period Ended 31 October 2024
| 13 months to 31 October 2024 | ||
|---|---|---|
| Average number of employees during the period |
|
During the financial year of Oct 2024-2025, Wellvitas was in a pre-trading planning phase. We were seeking premises in a targeted area of Glasgow that would enable us to maximise our social goals where there is both affluence to help financial sustainability but also a lot of health inequality and health depravation, well as an aged population to help benefit the most. There were no public facing activities during this period, and no financial transactions during this period.
No consultation with stakeholders
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
11 October 2025
And signed on behalf of the board by:
Name: Umme Maryam Aliah Mashroofah Chowdhury
Status: Director